Pharmaceutical Industry Information Portal

HomeNews

News

Top biopharma companies could be affected by Brazilian drug patent suspension

GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.

Falsified Remdesivir identified in WHO region of the Americas

WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products.

FDA Authorizes Additional COVID-19 Vaccine Dose for Certain Immunocompromised Individuals

The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna Vaccines and determined that the administration of third vaccine doses may increase protection in this population.

BratskChemSyntez and Reshetnev Siberian State University developed a training program for synthesis operators

The plant technologists and University teachers took part in the development. It will give a deeper understanding of the organic synthesis manufacturing process and...

Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing

The collaboration aims to provide Canadians with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza...

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs

The Solidarity PLUS trial is a platform trial that represents the largest global collaboration among WHO Member States.
spot_img

Expert Articles

spot_img